Identification of therapeutic targets for chemotherapy-resistant colon cancer stem cells
| dc.contributor.author | Francipane, M. G. | |
| dc.contributor.author | Bulanin, D. | |
| dc.contributor.author | Lagasse, E. | |
| dc.date.accessioned | 2016-05-31T03:13:47Z | |
| dc.date.available | 2016-05-31T03:13:47Z | |
| dc.date.issued | 2016-05 | |
| dc.description.abstract | Current first-line chemotherapy generally consists of cytotoxic agents. While these agents may initially control disease by effectively debulking tumors, the tumors invariably recur due to the ability of cancer stem cells (CSCs) to survive and repopulate the tumor mass. To identify potential molecular targets in 5-fluorouracil (5-FU) refractory colon CSCs, we developed 5-FU resistant cell lines over a period of a year. Here we show that 5-FU maintains colon CSCs in an undifferentiated state in vitro. | ru_RU |
| dc.identifier.citation | M. G. Francipane, D. Bulanin, and E. Lagasse. 2016. Identification of therapeutic targets for chemotherapy-resistant colon cancer stem cells. Abstract book. 4 th International Scientific Conference “Regenerative medicine & healthy aging”. National Laboratory Astana, Nazarbayev University. http://nur.nu.edu.kz/handle/123456789/1531 | ru_RU |
| dc.identifier.uri | http://nur.nu.edu.kz/handle/123456789/1531 | |
| dc.language.iso | en | ru_RU |
| dc.publisher | National Laboratory Astana, NAZARBAYEV UNIVERSITY | ru_RU |
| dc.rights | Attribution-NonCommercial-ShareAlike 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/us/ | * |
| dc.subject | cancer stem cells | ru_RU |
| dc.subject | cancer | ru_RU |
| dc.title | Identification of therapeutic targets for chemotherapy-resistant colon cancer stem cells | ru_RU |
| dc.type | Abstract | ru_RU |